• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

EVT:GR

3.683 EUR 0.045 1.21%

As of 13:55:05 ET on 08/29/2014.

Snapshot for Evotec AG (EVT)

Open: 3.744 Day's Range: 3.648 - 3.769 Volume: 592,386
Previous Close: 3.728 52wk Range: 2.600 - 5.175 1-Yr Rtn: +40.52%

Stock Chart for EVT

No chart data available.
  • EVT:GR 3.683
  • 1D
  • 1M
  • 1Y
3.728
Interactive EVT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EVT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 175.3810
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -0.2132
Est. EPS (EUR) (12/2014) 0.0210
Est. PEG Ratio -
Market Cap (M EUR) 485.00
Shares Outstanding (M) 131.68
30 Day Average Volume 1,229,243
Price/Book (mrq) 3.0889
Price/Sale (ttm) 5.1460
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EVT

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for EVT

Evotec AG offers drug research, development, and manufacturing services. The Company offers assay development and screening and compound optimization services to pharmaceutical companies. Evotec also develops drugs on its own for out-licensing.

Werner LanthalerChief Executive OfficerColin BondCFO/Member-Mgmt Board
Mario PolywkaCOO/Member-Mgmt BdCord E DohrmannChief Scientific Officer
More Company Profile & Key Executives for EVT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil